Paul A. Pearson
University of Kentucky
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul A. Pearson.
Archive | 2006
Glenn J. Jaffe; Paul Ashton; Paul A. Pearson
The present invention comprises a macrolide immunosuppressant at a concentration of less than 2% w / v for use in the treatment of ocular disorders by topical application to the eye and an amphiphilic carbohydrate compound having a molecular weight in the range of 1-50 kDa. Aqueous composition, wherein the amphiphilic carbohydrate compound is present in a concentration of less than 10% w / v relative to the composition. A preferred carbohydrate compound is quaternary ammonium palmitoyl glycol chitosan (GCPQ). Also provided are pharmaceutical compositions and methods of treatment. The treatment can be, for example, dry eye syndrome (DES), spring keratoconjunctivitis (VKC), eczema, atopic keratoconjunctivitis (AKC), Sjogrens syndrome, after refractive surgery, corneal transplantation or contact lens intolerance. [Selection figure] None
Archive | 1992
Thomas J. Smith; Paul Ashton; Paul A. Pearson
Archive | 1996
Paul Ashton; Paul A. Pearson
Archive | 2006
Glenn J. Jaffe; Paul Ashton; Paul A. Pearson
Archive | 2002
Paul Ashton; Paul A. Pearson; Thomas J. Smith; アシュトン ポール; ジェイ． スミス，トーマス; エー． ピアソン，ポール
Archive | 1996
Paul Ashton; Paul A. Pearson
Archive | 1996
Paul Ashton; Paul A. Pearson
Archive | 1992
Thomas J. Smith; Paul Ashton; Paul A. Pearson
Archive | 1992
Paul Ashton; Paul A. Pearson; Thomas J. Smith
Archive | 1992
Thomas J. Smith; Paul Ashton; Paul A. Pearson
Collaboration
Dive into the Paul A. Pearson's collaboration.
